Clinical Trials Logo

Clinical Trial Summary

This is a prospective multicenter cohort study to evaluate the prognostic value of new biological markers in predicting thrombotic events after orthopedic surgery. According to the inclusion and non-inclusion criteria below, the study will include 387 major subjects who will undergo first-line total knee replacement and will receive the same standard prophylactic treatment: anticoagulation with Lovenox® (enoxaparin) 4000 IU/d subcutaneously 6 to 8 hours postoperatively and then daily for 15 days in combination with compression stockings.


Clinical Trial Description

Recruitment and follow-up of patients will be carried out in 3 hospitals by the respective orthopedic teams. Three hundred and eighty-seven patients will be included in the study, over a period of 36 months: 200 in Marseille, 100 in Nice and 87 in Nîmes. The objective of the study was to evaluate the prognostic capacities of the coagulolytic balance of MVs measured after surgery at D0 in the occurrence of a symptomatic or asymptomatic venous thromboembolic event revealed by echodoppler at 1 month after total knee replacement surgery. The management of the subjects is unchanged from the current recommendations and will be homogeneous between the three inclusion centers. Patients will be hospitalized for 5 days and will receive the usual prophylactic anticoagulant treatment with Lovenox® (enoxaparin sodium; LMWH) 4000 IU/d subcutaneously 6 to 8 hours postoperatively and then daily for 15 days in combination with compression stockings, which corresponds to the management of a PTG according to current recommendations. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05387694
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact Matthieu OLLIVIER
Phone 04.91.74.50.12
Email matthieu.ollivier@ap-hm.fr
Status Not yet recruiting
Phase N/A
Start date June 2023
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06134999 - Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation N/A
Recruiting NCT06346717 - Mobile Application Based Care for Total Knee Prosthesis Patients N/A
Completed NCT01864434 - In Vivo Kinematics Comparison of Stryker or Zimmer Total Knee Arthroplasty
Completed NCT05233423 - Pressurized Cold Application for Patients Total Knee Prosthesis Surgery N/A
Recruiting NCT06367842 - Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)
Completed NCT03634124 - Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs Phase 3
Completed NCT01290627 - In Vivo Determination of 3D Patellofemoral Mechanics
Completed NCT01290640 - Comparison of Kinematics for Subjects Implanted With a PFC Sigma Rotating Platform or Fixed Bearing TC3 Prosthesis
Completed NCT02319915 - Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation. Early Phase 1
Completed NCT02018484 - Positioning of the Tibial Cut in Unicompartmental Medial Knee Replacement by Using Patient Specific Cutting Guides. N/A
Completed NCT01714492 - Mechanics Analysis of Patients Having a Sigma Mobile Bearing TKA